Compare NUTX & XBIT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | NUTX | XBIT |
|---|---|---|
| Founded | 2011 | 2005 |
| Country | United States | United States |
| Employees | 944 | 88 |
| Industry | Retail: Computer Software & Peripheral Equipment | Pharmaceuticals and Biotechnology |
| Sector | Technology | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 1.2B | 71.3M |
| IPO Year | 2009 | 2015 |
| Metric | NUTX | XBIT |
|---|---|---|
| Price | $88.65 | $2.32 |
| Analyst Decision | Strong Buy | |
| Analyst Count | 2 | 0 |
| Target Price | ★ $252.50 | N/A |
| AVG Volume (30 Days) | ★ 172.3K | 24.6K |
| Earning Date | 01-01-0001 | 01-01-0001 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ 7.93 | N/A |
| EPS | ★ 10.48 | N/A |
| Revenue | ★ $875,257,000.00 | N/A |
| Revenue This Year | $18.71 | N/A |
| Revenue Next Year | $2.79 | N/A |
| P/E Ratio | $8.31 | ★ N/A |
| Revenue Growth | ★ 82.36 | N/A |
| 52 Week Low | $45.88 | $2.09 |
| 52 Week High | $193.07 | $3.62 |
| Indicator | NUTX | XBIT |
|---|---|---|
| Relative Strength Index (RSI) | 35.11 | 45.90 |
| Support Level | $81.70 | $2.32 |
| Resistance Level | $110.29 | $2.69 |
| Average True Range (ATR) | 8.40 | 0.10 |
| MACD | -0.34 | 0.01 |
| Stochastic Oscillator | 11.50 | 43.10 |
Nutex Health Inc is healthcare services and operations company with 20 hospital facilities in eight states (hospital division), and a primary care-centric, risk-bearing population health management division. The hospital division implements and operates healthcare models, including micro-hospitals, specialty hospitals and hospital outpatient departments (HOPDs). The population health management division owns and operates provider networks such as independent physician associations (IPAs) and offers a cloud-based proprietary technology platform to IPAs that aggregates clinical and claims data across multiple settings, information systems and sources to create a holistic view of patients and providers.
XBiotech Inc is a United States-based clinical-stage biopharmaceutical company. The company is engaged in discovering and developing True Human (antibody technology) monoclonal antibodies for treating a variety of diseases. The company focuses on developing Anti-inflammatory therapeutic antibodies as a treatment for cancer. Geographically, all of its operations are in the United States.